Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05488431 |
|
Recruitment Status :
Not yet recruiting
First Posted : August 4, 2022
Last Update Posted : January 9, 2023
|
Sponsor:
Priscilla Hsue, MD
Collaborators:
University of California, Los Angeles
University of Utah
Massachusetts General Hospital
Information provided by (Responsible Party):
Priscilla Hsue, MD, University of California, San Francisco
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | February 1, 2028 |
| Estimated Study Completion Date : | February 1, 2028 |